Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
cnbc.com/2025/05/02/inside-the-deal-roche-zealand-pharmas-5point3-billion-obesity-drug-bet.htmlThe ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech Zealand Pharma's "next generation" weight loss drug.
This story appeared on cnbc.com, 2025-05-02 05:19:05.